152 related articles for article (PubMed ID: 1551112)
1. Inhibition of p34cdc2 kinase activation, p34cdc2 tyrosine dephosphorylation, and mitotic progression in Chinese hamster ovary cells exposed to etoposide.
Lock RB
Cancer Res; 1992 Apr; 52(7):1817-22. PubMed ID: 1551112
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of p34cdc2 kinase activity by etoposide or irradiation as a mechanism of G2 arrest in Chinese hamster ovary cells.
Lock RB; Ross WE
Cancer Res; 1990 Jun; 50(12):3761-6. PubMed ID: 2187601
[TBL] [Abstract][Full Text] [Related]
3. Cell cycle-dependent cytotoxicity, G2/M phase arrest, and disruption of p34cdc2/cyclin B1 activity induced by doxorubicin in synchronized P388 cells.
Ling YH; el-Naggar AK; Priebe W; Perez-Soler R
Mol Pharmacol; 1996 May; 49(5):832-41. PubMed ID: 8622633
[TBL] [Abstract][Full Text] [Related]
4. Phorbol ester TPA rapidly prevents activation of p34cdc2 histone H1 kinase and concomitantly the transition from G2 phase to mitosis in synchronized HeLa cells.
Barth H; Kinzel V
Exp Cell Res; 1994 Jun; 212(2):383-8. PubMed ID: 8187833
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor rapidly impairs activation of p34cdc2 protein kinase in HeLa cells at the G2-M boundary.
Barth H; Kinzel V
J Cell Physiol; 1995 Jan; 162(1):44-51. PubMed ID: 7814450
[TBL] [Abstract][Full Text] [Related]
6. The G2 block induced by DNA damage: a caffeine-resistant component independent of Cdc25C, MPM-2 phosphorylation, and H1 kinase activity.
Barratt RA; Kao G; McKenna WG; Kuang J; Muschel RJ
Cancer Res; 1998 Jun; 58(12):2639-45. PubMed ID: 9635591
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the cell cycle at the G2/M boundary in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking p34cdc2 kinase activity.
Arita Y; Buffolino P; Coppock DL
Exp Cell Res; 1998 Aug; 242(2):381-90. PubMed ID: 9683525
[TBL] [Abstract][Full Text] [Related]
8. Growth condition-induced precocious activation of p34cdc2 kinase inhibits the expression of developmental competence.
Jantzen H; Schulze I
Dev Biol; 1994 Nov; 166(1):311-22. PubMed ID: 7958455
[TBL] [Abstract][Full Text] [Related]
9. Possible role for p34cdc2 kinase in etoposide-induced cell death of Chinese hamster ovary cells.
Lock RB; Ross WE
Cancer Res; 1990 Jun; 50(12):3767-71. PubMed ID: 2187602
[TBL] [Abstract][Full Text] [Related]
10. The role of cell cycle progression in cisplatin-induced apoptosis in Chinese hamster ovary cells.
Demarcq C; Bunch RT; Creswell D; Eastman A
Cell Growth Differ; 1994 Sep; 5(9):983-93. PubMed ID: 7819136
[TBL] [Abstract][Full Text] [Related]
11. The involvement of active DNA synthesis in camptothecin-induced G2 arrest: altered regulation of p34cdc2/cyclin B.
Tsao YP; D'Arpa P; Liu LF
Cancer Res; 1992 Apr; 52(7):1823-9. PubMed ID: 1312900
[TBL] [Abstract][Full Text] [Related]
12. [Effect of cisplatin on cell cycle regulators].
Nishio K; Saijo N
Gan To Kagaku Ryoho; 1994 Feb; 21(3):289-94. PubMed ID: 8109984
[TBL] [Abstract][Full Text] [Related]
13. Role of cdc25-C phosphatase in the immediate G2 delay induced by the exogenous factors epidermal growth factor and phorbolester.
Barth H; Hoffmann I; Klein S; Kaszkin M; Richards J; Kinzel V
J Cell Physiol; 1996 Sep; 168(3):589-99. PubMed ID: 8816913
[TBL] [Abstract][Full Text] [Related]
14. Involvement of the Fanconi's anemia protein FAC in a pathway that signals to the cyclin B/cdc2 kinase.
Kruyt FA; Dijkmans LM; Arwert F; Joenje H
Cancer Res; 1997 Jun; 57(11):2244-51. PubMed ID: 9187128
[TBL] [Abstract][Full Text] [Related]
15. Activation of p34cdc2 coincident with taxol-induced apoptosis.
Donaldson KL; Goolsby GL; Kiener PA; Wahl AF
Cell Growth Differ; 1994 Oct; 5(10):1041-50. PubMed ID: 7848905
[TBL] [Abstract][Full Text] [Related]
16. Concentration-dependent differences in the mechanisms by which caffeine potentiates etoposide cytotoxicity in HeLa cells.
Lock RB; Galperina OV; Feldhoff RC; Rhodes LJ
Cancer Res; 1994 Sep; 54(18):4933-9. PubMed ID: 8069859
[TBL] [Abstract][Full Text] [Related]
17. Maitotoxin, a calcium channel activator, inhibits cell cycle progression through the G1/S and G2/M transitions and prevents CDC2 kinase activation in GH4C1 cells.
Van Dolah FM; Ramsdell JS
J Cell Physiol; 1996 Jan; 166(1):49-56. PubMed ID: 8557775
[TBL] [Abstract][Full Text] [Related]
18. Screening for antimitotic compounds using the cdc25 tyrosine phosphatase, an activator of the mitosis-inducing p34cdc2/cyclin Bcdc13 protein kinase.
Baratte B; Meijer L; Galaktionov K; Beach D
Anticancer Res; 1992; 12(3):873-80. PubMed ID: 1320360
[TBL] [Abstract][Full Text] [Related]
19. [From ovocyte to biochemistry of the cell cycle].
Ozon R
Verh K Acad Geneeskd Belg; 1991; 53(4):365-85. PubMed ID: 1659057
[TBL] [Abstract][Full Text] [Related]
20. Biochemical differences between staurosporine-induced apoptosis and premature mitosis.
Yoshida M; Usui T; Tsujimura K; Inagaki M; Beppu T; Horinouchi S
Exp Cell Res; 1997 May; 232(2):225-39. PubMed ID: 9168797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
